Navigation Links
DuoVisc

ProductsDuoVisc
Company Alcon Laboratories
Item DuoVisc
Features 
  • DUOVISC viscoelastic system provides the dispersive benefits of VISCOAT and the cohesive benefits of PROVISC in one single-packaged, single-priced system.
  • DUOVISC Viscoelastic System is designed to give two viscoelastic materials with different physiochemical properties that can be used differently and sequentially to perform specific tasks during a cataract procedure
Description DUOVISC Viscoelastic System is designed to give two viscoelastic materials with different physicochemical properties that can be used differently and sequentially to perform specific tasks during a cataract procedure. The choice of the viscoelastic is based upon an understanding of the differential ability of each to facilitate performance of the surgical task at hand. DUOVISC Viscoelastic System consists of VISCOAT. Viscoelastic Solution and PROVISC Viscoelastic Material. The use of VISCOAT Viscoelastic Solution in the initial phases of the anterior segment surgery takes advantage of VISCOAT Viscoelastic Solutions demonstrated tissue protection (1-3) properties. The use of PROVISC Viscoelastic Material during the later phases of the anterior segment surgery takes advantage of the physicochemical properties that make it better suited for the expansion of the capsular bag and facilitation of intraocular lens implantation following the cataract extraction with VISCOAT.

Healon is a sterile, nonpyrogenic, viscoelastic preparation supplied in disposable glass syringes, delivering 0.85 mL, 0.55 mL or 0.4 mL sodium hyaluronate (10 mg/mL) dissolved in physiological sodium chloridephosphate buffer (pH 7.0-7.5). Each mL of Healon contains 10 mg of sodium hyaluronate, 8.5 mg sodium chloride, 0.28 mg of disodium hydrogen phosphate dihydrate, 0.04 mg of sodium dihydrogen phosphate hydrate and q.s. water for injection U.S.P. Healon syringes are terminally sterilized and aseptically packaged.

A sterile single-use 27 G cannula is enclosed in the 0.4 mL, 0.55 mL, and 0.85 mL boxes.

Info Alcon Laboratories
Customer Service: (800) 757-9195
Web site: http://www.alconlabs.com/

Related medicine products :

1. No.12 Surgical Blade
2. No. SM68 Surgical Blade
3. Surgiscribe Surgical Marking Pens
4. Surgical Markers
5. TLS Surgical Markers
6. SQUEEZE-MARK Surgical Markers
7. Ultra MD40 Super Pulse CO2 Surgical Laser
8. Ultra MD 60 Super Pulse CO2 Surgical Laser
9. Ultra MD 80 Super Pulse CO2 Surgical Laser
10. Reliance Mobile Surgical Stretcher
11. Ocular Posner Diagnostic And Surgical Gonioprism
TAG: DuoVisc
mobileMICROMEDEX™ gives physicians, pharmacists, and other healthcare professionals reliable clinical information to help support and confirm treatment decisions. Clinicians can trust the data i
Focuses primarily on the drugs used for treatment and symptom management for colorectal cancer.
Portable Drug Companion is a comprehensive, authoritative drug reference to chose from over 5,500 entries, with overdose management, Canadian drug names, OTC and herbal remedies. This "Mini-Suite" of
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy.
Medicine Products:
(Date:12/3/2008)...sters feel better mentally, physically, researcher...ews) -- Overweight kids may be able to work out th... A study of sedentary but otherwise healthy 7- to ...and anger issues by taking part in a 10- to 15-wee...ng applied to children across lines such as race, ...
(Date:12/3/2008)...ing less responsible uses, claims, experts say , ...Expensive, sham stem cell therapies are being hawk...t, experts say. , In response, the leading orga...ed guidelines to steer research in the field towar...earch is progressing so rapidly and has sparked a ...
(Date:12/3/2008)...Interleukin-12 is a naturally occurring protein es...mune system. Having either too much or too little ...of many diseases, including some cancers and auto-...matoid arthritis. In turn, modulating interleukin-...itions. , In an effort to create a new and cost-...
(Date:12/3/2008)...tive osteoporosis treatment could soon be a realit... accurately at which point someone needs further d...rranted, has been developed by The National Osteop... relying primarily on Bone Mineral Density (BMD) m... do, their approach takes into account both the ri...
Breaking Medicine News(10 mins):Health News:Bogus Stem Cell Therapies Sold on Internet 2Health News:Bogus Stem Cell Therapies Sold on Internet 3Health News:Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants 2Health News:Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants 3Health News:WHO tool helps target bone treatment 2
...the only bird to have shown the H5N1 virus bird fl...ith the infection and health // officials are now ...t a native species. This has calmed fears of a pan...f veterinary officers admitted that they were unaw...
...e given to a condition characterized by a “thick” ...ugh it remains one of the toughest // conditions f...e condition affects women more than men and is pro...e. It may also be seen in patients with type 2 di...
...ed smuggled bird and poultry parts or in whole.// ...ts found bags of duck feet. Also a similar raid at...million packages of chicken meat smuggled from Chi...is increasing evidence that a thriving internation...
...at the University of Alberta people who do not wea...mpared to people who wear them. // In addition Dr.... Research Lab states that young attractive people ...most neglectful child caretakers of all. His conc...
Other Medicine News:Health News:Smuggling could also be a carrier to bird flu spread. 2Health News:Get that wedding ring on if you want to be branded a responsible parent! 2
(Date:11/27/2008)...ty of acute lymphoblastic leukemia relapse cases a...agnosis , , MEMPHIS, Tenn., Nov. 27 /PRNews...n,s Research Hospital have identified distinctive ...th acute lymphoblastic leukemia (ALL) that cause r...treatments for ALL relapse in children and, ultima...
(Date:11/26/2008)...ity, automation and intelligent clinical applicati...ll new level , , CHICAGO, Ill., Nov. 26 /PR...w.siemens.com/healthcare ) highlights the ACUSON ...), the world,s first multi-use, automated volume ...ssembly and Annual Meeting of the Radiological Soc...
(Date:11/25/2008)...ove recovery , , Audio and Web Video Resour...ayo Clinic News Blog. Please see the bottom of thi...Minn., Nov. 25 A Mayo C...n,t think they,re having a stroke -- and as a resu...n worsens. The findings appear in the current issu...
(Date:11/25/2008)...dents against expanding statin use broadly in wake....J., Nov. 25 JUPITER, a clinical t...ascular risk of healthy patients with elevated CRP...adults, according to a national poll directed at h...part in the online poll conducted by medical news ...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3NeurogesX to Report Third Quarter 2007 Financial Results on November 14 2007 5891 1NeurogesX to Report Third Quarter 2007 Financial Results on November 14 2007 5891 2NeurogesX to Report Third Quarter 2007 Financial Results on November 14 2007 5891 3Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference 1742 1Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference 1742 2Religion and psychology 5886 1UBC researchers discover instruction manual that tells cancers how to hide from immune system 5882 1
..., 4th May 2007 - CeNeS Pharmaceuticals plc,(LSE: C..., notes,the publication of an independent study in...s Phase II NMDA antagonist, CNS 5161. CeNeS,is dev...opathic,pain. The independent study builds on the ...61. , In the study reported in ,Synapse, Dr Anat ...
...BUSINESS WIRE)--May 4, 2007 - New data from a,rand...on of,COPAXONE(R) (glatiramer acetate injection) a...T1 Gadolinium (Gd)-enhancing lesions,of the brain ...apsing-remitting multiple sclerosis (RRMS), as mea...d to those receiving,COPAXONE(R) alone. Additional...
Other Medicine Technology:Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5